Test Price
2,500 AED✅ Home Collection Available
Plasminogen Activator Inhibitor-1 (PAI-1) Test in UAE | 2500 AED | DHA-Certified Coagulation Assay
Executive Summary & Core Metrics
The Plasminogen Activator Inhibitor-1 (PAI-1) assay is a specialised quantitative coagulation test measuring the primary inhibitor of tissue plasminogen activator, providing a direct assessment of fibrinolytic capacity. Elevated PAI-1 levels represent an independent risk factor for venous thromboembolism, coronary artery disease, and recurrent pregnancy loss. This test is essential for Emirati patients presenting with unexplained thrombotic events or a positive family history of thrombophilia.
- Diagnostic Precision: 99.9% sensitivity using ISO 9001:2015 validated enhanced ELISA methodology.
- Specimen Handling: Dedicated temperature-controlled cold-chain home collection with immediate plasma separation and flash freezing at -20°C.
- Clinical Support: Complimentary post-result teleconsultation with a DHA-licensed General Practitioner for comprehensive result interpretation.
- Insurance Facilitation: Direct billing verification via WhatsApp +971 54 548 8731 (daily 8 AM – 11 PM).
Test Overview & Methodology
This assay employs a validated enhanced enzyme-linked immunosorbent assay (ELISA) technique cross-referenced against liquid chromatography-tandem mass spectrometry (LC-MS/MS) to ensure maximum specificity for human PAI-1 antigen. The test measures active and latent forms of the inhibitor in platelet-poor plasma, offering a comprehensive view of fibrinolytic regulation.
| Feature | Our Test (DHA-Certified) | Standard External Lab |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity, ISO 9001:2015 validated | Standard EIA, no guaranteed sensitivity threshold |
| Methodology | Enhanced ELISA validated against LC-MS/MS reference | Conventional ELISA without mass spectrometry cross-validation |
| Turnaround Time | Sample submission by 7th of month; report within 2–3 weeks | Variable, often exceeding 4 weeks |
| Logistics | VIP mobile phlebotomy with temperature-controlled cold-chain home collection | Patient-arranged transport without cold-chain guarantees |
Physician Insight & Safety Protocols
Dr. Ajay Singh | General Practitioner | DHA Registration ID: 36234132
“A single PAI-1 measurement must be interpreted within the broader clinical context. Elevated levels can arise from inflammatory states, metabolic syndrome, or circadian fluctuations. I routinely integrate this result with genetic thrombophilia panels and the patient’s thromboembolic history before drawing any therapeutic conclusions. This assay serves as a directional guide for prevention and personalised risk stratification, not as a standalone trigger for anticoagulation changes.”
Advisory Precautions for Test Optimisation
Key Pre-Test Considerations
- Avoid phlebotomy during acute thrombotic events, within 4 weeks of major surgery, or during active infections to prevent transient PAI-1 elevation.
- Inform your physician about pregnancy or hormone replacement therapy, as these physiological states can temporarily increase PAI-1 concentrations.
- Do not modify or discontinue any prescribed anticoagulant regimen based solely on this test result without explicit consultation with your treating doctor.
Exclusion Criteria & Emergency Red Flags
Absolute Contraindications for Testing
- Testing is deferred during acute myocardial infarction, pulmonary embolism, or deep vein thrombosis until clinical stabilisation is achieved.
- Patients on concurrent heparin or direct oral anticoagulants should discuss timing of blood draw with their haematologist to avoid assay interference.
- If you experience sudden chest pain, unilateral leg swelling, dyspnoea, or haemoptysis, proceed immediately to the nearest emergency department without waiting for test results.
Patient FAQ & Clinical Guidance
1. What does the PAI-1 test measure and why is it clinically relevant in the UAE?
This assay quantifies plasminogen activator inhibitor-1, the primary regulator of fibrinolysis. Elevated concentrations indicate impaired clot dissolution, which is particularly relevant in the Emirati population where consanguinity can amplify inherited thrombophilic tendencies. The test helps physicians identify patients at risk for recurrent venous thrombosis, coronary events, and pregnancy complications.
2. What preparation is required before the blood draw?
A 12-hour fast is mandatory, and patients must abstain from smoking and strenuous exercise for 24 hours prior to phlebotomy. Inform your doctor about all medications, especially anticoagulants and hormonal therapies, as these can influence PAI-1 levels. The sample must be collected in a sodium citrate (blue-top) tube between 8 AM and 10 AM to standardise circadian variability.
3. How is the blood sample handled to ensure diagnostic accuracy?
The phlebotomist draws blood into a chilled sodium citrate tube, centrifuges it within 30 minutes to obtain platelet-poor plasma, and immediately flash-freezes the aliquot at -20°C. The frozen specimen is transported on dry ice without any thaw-refreeze cycle, accompanied by a completed Send Out Consent Form (Form 35). Any breach in this strict cold-chain protocol invalidates the assay, making proper logistics essential for reliable results.
4. When will I receive my PAI-1 test results and what happens afterwards?
Samples must reach our laboratory by the 7th day of each calendar month. Reports are issued within 2 to 3 weeks from receipt. Once your report is ready, you will receive a complimentary teleconsultation with a DHA-licensed general practitioner who will explain the clinical implications and discuss any necessary follow-up investigations or specialist referrals.
UAE Regulatory & Data Privacy Adherence
Data Protection & Clinical Governance Framework
This diagnostic service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) for all patient health information processing, and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, which governs the secure handling of electronic medical records and telemedicine communications. Clinical testing safety and patient consent protocols adhere strictly to Federal Decree-Law No. 4 of 2016 on Medical Liability. All home phlebotomy services are performed by DHA-licensed practitioners following MOHAP-approved infection control and specimen transport guidelines.
Direct Billing & Appointment Support: WhatsApp +971 54 548 8731 (available daily 8 AM – 11 PM).
Clinical & Logistical Metadata
| Test Name | Plasminogen Activator Inhibitor-1 (PAI-1) Antigen Assay |
| Price (AED) | 2,500 AED |
| Turnaround Time | 2–3 weeks (sample submission by 7th of month required) |
| Sample Type / Matrix | Peripheral whole blood collected in sodium citrate (blue-top) tube; platelet-poor plasma separated and flash-frozen at -20°C |
| Methodology Used | Enhanced Enzyme-Linked Immunosorbent Assay (ELISA) validated against LC-MS/MS reference standard |
| ICD-10-CM Code | D68.6 (Other thrombophilia) |
| LOINC Code | 13834-5 (Plasminogen activator inhibitor 1 [Mass/volume] in Platelet poor plasma) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians